Allozyne Analysis: $34M Raised
What is Allozyne?
Technologies for protein-based therapeutics
Location
Seattle, United States
Employees
11-50
Founded
2005
Product Features & Capabilities
- PEGylated IFN beta for multiple sclerosis treatment
Use Cases
Enhance efficacy of protein therapeutics; Improve safety profiles of biologics; Optimize dosing regimens for therapeutic proteins; Develop vaccines with improved characteristics; Support research in protein-based drug development
How much Allozyne raised
Funding - $34M
Other Considerations
Acquired by MedImmune; Active in the biotechnology sector; Focused on therapeutics for healthcare
See something that needs updating? Suggest edits to this profile.